In vitro testing for the risk of arachnoiditis from myelographic contrast media.
The risk of arachnoiditis from aqueous myelographic contrast media has been assayed reliably only in experimental animals. The effect of contrast media on protein and collagen production by fibroblasts in vitro was studied. Iocarmate, metrizamide, and iopamidol added to the culture medium caused cells to produce more protein and collagen. The degree to which the contrast medium stimulated collagen production correlated with the risk of arachnoiditis from the intrathecal use of the contrast medium. In vitro testing appears to be an effective assay for arachnoiditis.
D001100:Arachnoiditis / Q000139:chemically induced*; D003094:Collagen / Q000096:biosynthesis; D003287:Contrast Media / Q000633:toxicity*; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007479:Iopamidol; D007483:Iothalamic Acid / Q000031:analogs & derivatives / Q000633:toxicity; D008297:Male; D008793:Metrizamide / Q000633:toxicity; D009192:Myelography / Q000009:adverse effects*; D014176:Protein Biosynthesis; D013268:Stimulation, Chemical
D003287:Contrast Media; D007483:Iothalamic Acid; C010999:iocarmic acid; D003094:Collagen; D007479:Iopamidol; D008793:Metrizamide